Implementation of EPID transit dosimetry based on a through-air dosimetry algorithm.

Med Phys

Department of Applied Physics and Applied Mathematics, Columbia University, New York, New York 10027, USA.

Published: January 2012

Purpose: A method to perform transit dosimetry with an electronic portal imaging device (EPID) by extending the commercial implementation of a published through-air portal dose image (PDI) prediction algorithm Van Esch et al. [Radiother. Oncol. 71, 223-234 (2004)] is proposed and validated. A detailed characterization of the attenuation, scattering, and EPID response behind objects in the beam path is used to convert through-air PDIs into transit PDIs.

Methods: The EPID detector response beyond a range of water equivalent thicknesses (0-35 cm) and field sizes (3×3 to 22.2×29.6 cm(2)) was analyzed. A constant air gap between the phantom exit surface and the EPID was utilized. A model was constructed that accounts for the beam's attenuation along the central axis, the presence of phantom scattered radiation, the detector's energy dependent response, and the difference in EPID off-axis pixel response relative to the central pixel. The efficacy of the algorithm was verified by comparing predicted and measured PDIs for IMRT fields delivered through phantoms of increasing complexity.

Results: The expression that converts a through-air PDI to a transit PDI is dependent on the object's thickness, the irradiated field size, and the EPID pixel position. Monte Carlo derived narrow-beam linear attenuation coefficients are used to model the decrease in primary fluence incident upon the EPID due to the object's presence in the beam. This term is multiplied by a factor that accounts for the broad beam scatter geometry of the linac-phantom-EPID system and the detector's response to the incident beam quality. A 2D Gaussian function that models the nonuniformity of pixel response across the EPID detector plane is developed. For algorithmic verification, 49 IMRT fields were repeatedly delivered to homogeneous slab phantoms in 5 cm increments. Over the entire set of measurements, the average area passing a 3%∕3mm gamma criteria slowly decreased from 98% for no material in the beam to 96.7% for 35 cm of material in the beam. The same 49 fields were delivered to a heterogeneous slab phantom and on average, 97.1% of the pixels passed the gamma criteria. Finally, a total of 33 IMRT fields were delivered to the anthropomorphic phantom and on average, 98.1% of the pixels passed. The likelihood of good matches was independent of anatomical site.

Conclusions: A prediction of the transit PDI behind a phantom or patient can be created for the purposes of treatment verification via an extension of the Van Esch through-air PDI algorithm. The results of the verification measurements through phantoms indicate that further investigation through patients during their treatments is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.3665249DOI Listing

Publication Analysis

Top Keywords

imrt fields
12
fields delivered
12
transit dosimetry
8
epid
8
van esch
8
epid detector
8
pixel response
8
through-air pdi
8
transit pdi
8
gamma criteria
8

Similar Publications

Primary mediastinal B-cell lymphoma (PMBCL) is a rare form of aggressive B-cell lymphoma with a predominant onset in young patients. The minimization of potential (late) side effects is of cardinal interest for these patients. An anticipation of the individual risk profile is desirable to counsel the patient on the putative impact of radiotherapy (RT).

View Article and Find Full Text PDF

The National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) is a database that stores anonymized information on medical receipts and health checkups in Japan. The NDB Open Data is a publicly accessible summary table of the NDB database. To reveal annual trends and regional disparities in radiotherapy utilization in Japan, we analyzed the NDB Open Data tables for a 9-year period from 2014 to 2022.

View Article and Find Full Text PDF

Validation of a rapid algorithm for repeated intensity modulated radiation therapy dose calculations.

Biomed Phys Eng Express

December 2024

Department of Radiation Oncology, University of Iowa, Iowa City, IA, 52242, United States of America.

As adaptive radiotherapy workflows and deep learning model training rise in popularity, the need for repeated applications of a rapid dose calculation algorithm increases. In this work we evaluate the feasibility of a simple algorithm that can calculate dose directly from MLC positions in near real-time. Given the necessary machine parameters, the intensity modulated radiation therapy (IMRT) doses are calculated and can be used in optimization, deep learning model training, or other cases where fast repeated segment dose calculations are needed.

View Article and Find Full Text PDF

BACKGROUND Perivascular epitheloid cell neoplasm (PEComa) is a rare mesenchymal tumor that is evaluated in the same tumor family as angiomyolipoma, sugar cell tumor of the lung, and lymphangioleiomyomatosis. Immunohistochemically, the disease can express melanocytic and myogenic markers, such as HMB45, HMSA1, MelanA/Mart1, and actin. The disease can be seen in almost every organ, especially the uterus and retroperitoneum.

View Article and Find Full Text PDF

Introduction: Due to the rarity of mucosal melanomas, few recent studies can be found investigating the success and side effects of therapy for this entity with large numbers of patients. In this retrospective analysis, the efficacy and toxicity of combined intensity-modulated radiotherapy (IMRT) and carbon ion therapy (C12) of mucosal melanomas were analyzed to contribute to a better understanding of this rare disease.

Methods: Twenty-two patients were included from 2013 to 2022 in the Department of Radiation Oncology at Heidelberg University Hospital.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!